Abstract：OBJECTIVE: To study the effect of glutamine on intestinal barrier function by examining the changes of plasma D-lactic levels and diamine oxidase (DAO) levels in plasma and intestinal tissue after glutamine intervention in young rats with endotoxemia. METHODS: Eighty 18-day-old rats were randomly divided into endotoxemia and glutamine intervention groups (n=40 each). Endotoxemia was induced by lipopolysaccharide (LPS) injection. Plasma and small intestine homogenate were collected 1.5, 6, 24 and 72 hrs and 7 days after LPS injection. The glutamine intervention group was immediately administered with oral glutamine (2 g/kg) after LPS injection. Afterwards, glutamine was administered once daily. Plasma D-lactic and DAO levels and intestinal DAO levels were measured. RESULTS: Plasma DAO activity in the glutamine intervention group was significantly lower than that in the endotoxemia group 6 and 72 hrs after LPS injection (P<0.05). In contrast, the intestinal DAO activity in the glutamine intervention group was significantly higher than that in the endotoxemia group 6, 24 and 72 hrs and 7 days after LPS injection (P<0.05 or 0.01). Plasma D-lactic levels in the glutamine intervention group were significantly lower than those in the endotoxemia group 6, 24 and 72 hrs and 7 days after LPS injection (P<0.01). CONCLUSIONS: Glutamine may reduce the permeability of intestinal mucosa, and thus provides protective effects on intestinal barrier function in rats with endotoxemia.［Chin J Contemp Pediatr, 2010, 12 (10):809-811］
CHANG Xiao,WANG Lin-Lin,LIAN Shu-Jun et al. Effect of oral glutamine on intestinal barrier function in yaung rats with endotoxemia[J]. CJCP, 2010, 12(10): 809-811.
［6］De-Souza DA,Greene LJ. Intestinal permeability and systemic infections in critically ill patients:effect of glutamine［J］. Crit Care Med, 2005, 33(5):1125-1135.
［8］Deniel N, Marion-Letellier R, Charlione R, Tron F, Leprince J, Vaudry H, et al. Glutamine regulates the human epithelial intestinal HCT-8 cell proteome under apoptotic conditions［J］.Mol Cell Proteomics, 2007, 6(10):1671-1679.
［9］Kosenko E, Llansola M, Montoliu C, Monfort P, Rodrigo R, Hernandez-Viadel M, et al. Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide［J］. Neurochem Int, 2003, 43(4-5):493-499.
［10］Yeh SL, Lai YN, Shang HF, Lin MT, Chiu WC, Chen WJ. Effects of glutamine supplementation on splenocyte cytokine mRNA expression in rats with septic peritonitis［J］. World J Gastroenterol, 2005, 11(12):1742-1746.
［11］Kessel A, Toubi E, Pavlotzky E, Mogilner J, Coran AG, Lurie M, et al. Treatment with glutamine is associated with down-regulation of Tolllike receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat［J］. Clin Exp Immunol, 2008, 151(2):341-347.
